Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.

Stroke · 2019 · PMC6430592 · PMID 30869568

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Moreover, our results also suggest a clear trend of an appealing effectiveness profile for NOACs in comparison with warfarin in this population.

also in 19,460 other papers

did not reach statistical significanceno p-value reported

Our principal finding was that NOAC treatment was associated with a lower risk of ischemic stroke in comparison with warfarin, although the adjusted risk ratio did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.